These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3358802)

  • 1. Encapsulation of indomethacin in liposomes provides protection against both gastric and intestinal ulceration when orally administered to rats.
    Soehngen EC; Godin-Ostro E; Fielder FG; Ginsberg RS; Slusher MA; Weiner AL
    Arthritis Rheum; 1988 Mar; 31(3):414-22. PubMed ID: 3358802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium-salicylate in contrast with acetylsalicylic acid prevents gastric antral and intestinal ulcers produced by indomethacin in the refed rat.
    Ezer E
    Acta Physiol Hung; 1985; 65(3):263-6. PubMed ID: 4013765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal cytoprotection by indomethacin + sodium salicylate combination in rat.
    Ezer E; Matuz J; Pallagi K; Szporny L
    Acta Physiol Hung; 1984; 64(3-4):355-9. PubMed ID: 6532123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutropenia does not prevent etodolac- or indomethacin-induced gastrointestinal damage in the rat.
    Melarange R; Gentry C; Toseland CD; Smith PH; Fuller J
    Dig Dis Sci; 1995 Dec; 40(12):2694-703. PubMed ID: 8536533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of indomethacin amphoteric gel on gastric ulcerogenicity and absorption of indomethacin in rats.
    Liversidge GG; Dent J; Eickhoff WM
    Pharm Res; 1989 Jan; 6(1):44-8. PubMed ID: 2717517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,6-Dimethyl-4-oxo-1,6,7,8,9,9a-hexahydro-4H-pyrido(1,2-a)- pyrimidine-3-carboxamide (Ch-127) protects against the intestinal damage in rats caused by two weeks' daily administration of indomethacin.
    Knoll J; Gyires K; Hermecz I
    Drugs Exp Clin Res; 1987; 13(5):253-8. PubMed ID: 3500028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of gastric cytoprotective drugs (atropine, cimetidine, vitamin-A) on the indomethacin induced intestinal ulcers in rats.
    Beró T; Németh A; Mózsik G; Jávor T
    Acta Physiol Hung; 1984; 64(3-4):343-7. PubMed ID: 6532122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive effect of immunosuppressive agents against indomethacin-induced small intestinal ulcers in rats.
    Matsumoto T; Iida M; Nakamura S; Hizawa K; Kuroki F; Fujishima M
    Dig Dis Sci; 1994 Apr; 39(4):787-95. PubMed ID: 7512017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies on the mechanism of fat-free diet (FFD)--protection against indomethacin-induced intestinal ulcers in the rat.
    Evangelista S; Ciappi R; Ortolani C; Barzanti A; Meli A
    Proc Soc Exp Biol Med; 1985 May; 179(1):113-5. PubMed ID: 3991592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygen radical scavengers are protective against indomethacin-induced intestinal ulceration in the rat.
    Zahavi I; Fisher S; Marcus H; Heckelman B; Kiro A; Dinari G
    J Pediatr Gastroenterol Nutr; 1995 Aug; 21(2):154-7. PubMed ID: 7472901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective action of SCH 12223 against experimentally induced gastric and intestinal lesions.
    Chiu PJ; Barnett A; Siegel M; Brown AD; Gerhart C
    J Pharmacol Exp Ther; 1988 Aug; 246(2):578-84. PubMed ID: 3404447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and pharmacodynamic evaluation of liposomes of indomethacin.
    Srinath P; Vyas SP; Diwan PV
    Drug Dev Ind Pharm; 2000 Mar; 26(3):313-21. PubMed ID: 10738648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulphasalazine and experimental stress ulcers.
    Ogle CW; Cho CH; Dai S
    Agents Actions; 1985 Dec; 17(2):153-7. PubMed ID: 2869652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone is protective against indomethacin-induced intestinal ulceration in the rat.
    Waisman Y; Dinari G; Marcus H; Ligumsky M; Rosenbach Y; Zahavi I; Nitzan M
    Gastroenterology; 1985 Jul; 89(1):86-91. PubMed ID: 2989073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of intestinal ulceration induced by indomethacin, in rats.
    Ezer E
    Agents Actions; 1987 Jun; 21(1-2):173-6. PubMed ID: 3630854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.
    Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F
    Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin fails to induce ulceration in the gastrointestinal tract of newborn and suckling rats.
    Bedrick AD; Holtzapple PG
    Pediatr Res; 1986 Jul; 20(7):598-601. PubMed ID: 3725456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-dopa is protective against indomethacin-induced small intestinal ulceration in the rat: possible role of an alpha-2-adrenergic mechanism.
    Kiro A; Zahavi I; Marcus H; Dinari G
    Life Sci; 1992; 51(14):1151-6. PubMed ID: 1325590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility.
    Satoh H; Amagase K; Takeuchi K
    J Pharmacol Exp Ther; 2012 Nov; 343(2):270-7. PubMed ID: 22854201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of corticosteroids on indomethacin-induced intestinal ulceration in the rat.
    Derelanko MJ; Long JF
    Dig Dis Sci; 1980 Nov; 25(11):823-9. PubMed ID: 7438955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.